Price Alert

Medpace Inc. (MEDP)

NASDAQ: MEDP · Real-Time Price · USD

460.44

1.78 (0.39%)

At close: Aug 15, 2025, 12:15 PM

Medpace Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	603.31M	558.57M	536.59M	533.32M	528.1M	511.04M	498.4M	492.5M	460.87M	434.07M	394.1M	383.74M	351.21M	330.95M	308.55M	295.57M	278.29M	259.96M
Cost of Revenue	423.3M	380.22M	358.27M	364.31M	374.27M	355.9M	361.6M	359.31M	336.55M	303.88M	278.37M	264.71M	252.21M	232.27M	220.57M	208.47M	203.64M	181.54M
Gross Profit	180.01M	178.35M	178.32M	169.01M	153.84M	155.14M	136.81M	133.19M	124.32M	130.19M	115.73M	119.03M	99M	98.68M	87.98M	87.09M	74.65M	78.43M
Operating Income	126.33M	113.52M	125.38M	112.27M	105.15M	104.07M	87.32M	84.91M	78.39M	86.2M	76.43M	77.83M	60.24M	64.2M	54.85M	53.71M	42.45M	47.6M
Interest Income	1.08M	6.46M	7.88M	7.53M	5.46M	4.12M	1.84M	n/a	n/a	n/a	n/a	n/a	n/a	54K	n/a	n/a	n/a	n/a
Pretax Income	124.54M	118.17M	133.88M	118.78M	110.48M	112.78M	90.71M	83.2M	75.74M	86.03M	73.64M	81.89M	62M	65.32M	55.92M	54.74M	42.69M	48.51M
Net Income	90.26M	114.59M	117.02M	96.43M	88.35M	102.59M	78.3M	70.55M	61.07M	72.89M	68.67M	66.03M	49.36M	61.31M	50.03M	48.57M	39.93M	43.31M
Selling & General & Admin	46.66M	57.9M	45.43M	49.22M	41.45M	44.08M	42.51M	41.41M	39.4M	38.03M	33.4M	35.42M	33.22M	29.37M	27.66M	28.05M	26.97M	25.74M
Research & Development	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	7.01M	6.93M	7.51M	7.52M	7.24M	6.99M	6.97M	6.88M	6.52M	5.96M	5.9M	5.79M	5.54M	5.11M	5.46M	5.33M	5.23M	5.09M
Operating Expenses	53.68M	64.83M	52.94M	56.73M	48.69M	51.07M	49.49M	48.28M	45.92M	43.98M	39.3M	41.21M	38.76M	34.47M	33.13M	33.38M	32.2M	30.83M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	105K	1.37M	n/a	n/a	1.58M	548K	n/a	n/a	41K	27K	n/a
Selling & Marketing Expenses	n/a	n/a	1.5M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	476.98M	445.05M	411.21M	421.04M	422.95M	406.98M	411.08M	407.59M	382.48M	347.87M	317.67M	305.92M	290.97M	266.74M	253.7M	241.85M	235.84M	212.37M
Income Tax Expense	34.28M	3.58M	16.86M	22.35M	22.13M	10.19M	12.41M	12.65M	14.68M	13.14M	4.97M	15.87M	12.64M	4.01M	5.89M	6.16M	2.75M	5.2M
Shares Outstanding (Basic)	29.49M	30.39M	30.95M	31.05M	30.99M	30.84M	30.72M	30.63M	30.54M	31.01M	31.19M	31.01M	32.49M	34.92M	35.98M	31.01M	35.89M	35.75M
Shares Outstanding (Diluted)	30.16M	31.2M	32.01M	32.09M	32.09M	32M	31.82M	31.76M	31.57M	32.16M	32.42M	32.25M	33.7M	36.36M	37.74M	32.25M	37.71M	37.75M
EPS (Basic)	3.16	3.77	3.78	3.11	2.85	3.32	2.55	2.30	2.00	2.35	2.20	2.13	1.52	1.75	1.39	1.35	1.11	1.21
EPS (Diluted)	3.10	3.67	3.67	3.01	2.75	3.20	2.46	2.22	1.93	2.27	2.11	2.05	1.46	1.69	1.32	1.29	1.06	1.14
EBITDA	117.61M	120.45M	132.88M	119.79M	112.39M	111.06M	96.49M	91.79M	84.91M	92.16M	73.3M	89.27M	68.09M	69.31M	60.32M	60.11M	47.94M	52.69M
EBIT	124.54M	113.52M	125.38M	112.27M	105.15M	104.07M	89.52M	84.91M	78.39M	86.2M	67.4M	83.48M	62.55M	64.2M	54.85M	54.78M	42.71M	47.6M
Depreciation & Amortization	-6.93M	6.93M	7.51M	7.52M	7.24M	6.99M	6.97M	6.88M	6.52M	5.96M	5.9M	5.79M	5.54M	5.11M	5.46M	5.33M	5.23M	5.09M